PACdb: A database for cell-based pharmacogenomics

Pharmacogenetics and Genomics

Volumn 20, Issue 4, 2010, Pages 269-273

  Gamazon, Eric R ^a   Duan, Shiwei ^a,c   Zhang, Wei ^a   Huang, Rong Stephanie ^a   Kistner, Emily O ^a,b   Dolan, Mary Eileen ^a   Cox, Nancy J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c AGENCY FOR SCIENCE   (Singapore)

Author keywords

Drug response; Gene expression; Hapmap; Lymphoblastoid cell line; Pharmacogenomics; Single nucleotide polymorphism

Indexed keywords

CARBOPLATIN; CISPLATIN; CYTARABINE; DAUNORUBICIN; ETOPOSIDE;

ARTICLE; CELL PH; CELL PROLIFERATION; CONFOUNDING VARIABLE; CONTROLLED STUDY; CYTOTOXICITY; DATA BASE; GENE EXPRESSION; GENETIC VARIABILITY; HAPLOTYPE MAP; IC 50; LYMPHOBLASTOID CELL; PHARMACOGENETICS; PHARMACOGENOMICS; PHENOTYPE; PRIORITY JOURNAL; RACE DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ALTERNATIVE SPLICING; CELL LINE; DATABASES, GENETIC; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION; GENETIC ASSOCIATION STUDIES; HUMANS; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE;

ARA;

EID: 77950636427     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e328337b8d6     Document Type: Article

References (15)

1. Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, Gibbs RA, et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007;449:851-861.
2. Huang RS, Duan S, Klstner EO, Bleibel WK, Delaney SM, Fackenthal DL, et al. Genetic variants contributing to daunorubicln-lnduced cytotoxicity. Cancer Res 2008; 68:3161-3168.
3. Huang RS, Duan S, Shukla SJ, Kistner EO, Clark TA, Chen TX, ef a/. Identification of genetic variants contributing to Cisplatin-induced cytotoxicity by use of a genomewide approach. Am J Hum Genet 2007; 81:427-437. (Pubitemid 47330203)
4. Huang RS, Duan S, Bleibel WK, Kistner EO, Zhang W, Clark TA, et al. A genome-wide approach to Identify genetic variants that contribute to etoposide-induced cytotoxicity. Proc Natl Acad Sei U S A 2007; 104:9768-19763
5. Bleibel WK, Duan S, Huang RS, Kistner EO, Shukla SJ, Wu X, et al. Identification of genomic regions contributing to etoposide-induced cytotoxicity. Hum Genet 2009; 125:173-180.
6. Hartford CM, Duan S, Delaney SM, Mi S, Kistner EO, Lamba JK, et al. Population-specific genetic variants important in susceptibility to cytarablne arabinoside cytotoxicity. Blood 2009; 113:2145-2153.
7. Huang RS, Kistner EO, Bleibel WK, Shukla SJ, Dolan ME. Effect of population and gender on chemotherapeutic agent-induced cytotoxicity. Mol Cancer Ther 2007; 6:31-36.
8. Cheung VG, Spielman RS. Genetics of human gene expression: mapping DNA variants that influence gene expression. Nat Rev Genet 2009; 10:595-604.
9. Zhang W, Duan S, Kistner EO, Bleibel WK, Huang RS, Clark TA, et al. Evaluation of genetic variation contributing to differences in gene expression between populations. Am J Hum Genet 2008; 82:631-640.
10. Huang RS, Duan S, Kistner EO, Hartford CM, Dolan ME. Genetic variants associated with carboplatin-induced cytotoxicity in cell lines derived from Africans. MoI Cancer Ther 2008; 7:3038-3046.
11. Abecasis GR, Cardon LR, Cookson WO. A general test of association for quantitative traits In nuclear families. Am J Hum Genet 2000; 66:279-292.
12. Storey JD, Tibshirani R. Statistical significance for genomewlde studies. Proc Natl Acad Sci USA 2003; 100:9440-9445.
13. Gamazon ER, Zhang W, Konkashbaev A, Duan S, Kistner EO, Nicolae DL, et al. SCAN: SNP and Copy Number Annotation. Bioinformatics 2010; 26:259-262.
14. Duan S, Bleibel WK, Wisel SA, Huang RS, Wu X, He L, et al. Identification of common genetic variants that account for transcript ¡soform variation between human populations. Hum Genet 2009; 125:81-93.
15. Sakai W, Swisher EM, Karlan BY, Agarwal MK, Higgins J, Friedman C, et al. Secondary mutations as a mechanism of cisplatin resistance in BRCA2mediated cancers. Nature 2008; 451:1116-1120.